Form 4: Bessemer Venture Partners Sells Hinge Health Shares

Director Elliott Robinson reports the sale of Hinge Health Class A Common Stock by Bessemer Venture Partners funds.

Summary

• Bessemer Venture Partners X L.P. and Bessemer Venture Partners X Institutional L.P. sold a total of 300,000 shares on May 7, 2026.
• An additional 200,000 shares were sold by the same entities on May 8, 2026.
• The May 7 sales occurred at a weighted average price of $54.77 per share.
• The May 8 sales occurred at a weighted average price of $55.16 per share.
• Elliott Robinson, a director at Hinge Health and partner at Bessemer, disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event; while insider selling can be perceived negatively, this is a routine liquidity event for a venture capital firm.

Positives

• The shares were sold at a healthy price range between $54.10 and $56.02, indicating strong market valuation for the company.

Negatives

• Significant divestment by a major venture capital firm may signal a reduction in long-term institutional commitment.

Risks

• Potential downward pressure on share price due to the liquidation of 500,000 shares by a major institutional holder.

Future Outlook

No specific forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that venture capital firms often divest portions of their holdings as companies mature or as fund lifecycles reach their conclusion, which is a standard practice in the private equity and venture capital industry.

Comparison to Industry Standards

• The sale of shares by venture capital firms post-IPO or during growth phases is consistent with standard liquidity events for early-stage investors.
• The pricing achieved is consistent with current market valuations for high-growth health-tech companies.

Related Party Transactions

• The reporting person is a partner at Bessemer Venture Partners and holds an indirect economic interest in the shares sold by the Bessemer Funds.

Stakeholder Impact

• Shareholders may experience short-term volatility due to the volume of shares sold into the market.

Key Dates

Keywords

Hinge Health, HNGE, Bessemer Venture Partners, Insider Trading, Form 4, Equity Sale